CTRI/2016/11/007429招募中4 期
A PROSPECTIVE, RANDOMIZED, DOUBLE BLIND CLINICAL STUDY OF COMPARISION OF HEMODYNAMIC EFFECTS AND INTRAOCULAR PRESSURE OF ETOMIDATE AND MIDAZOLAM DURING MONITORED ANAESTHESIA CARE IN PATIENTS OF HYPERTENSION AND CORONARY ARTERY DISEASE UNDERGOING CATARACT SURGERY
SIR TAKHTSINHJI HOSPITA0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Informed written consent for participation of study.
- •2)Patient having hypertension or coronary artery disease
- •3)Age:40 to 80
- •4)ASA physical status I,II, and III
- •5)Patients of either sex
- •6)Adequate fasting period -nil by mouth 6 hours for solid, 4 hours for liquid
排除标准
- •1)Patient refusing for consent
- •2)Known or predicted airway difficulty
- •3)Alcohol or drug addiction
- •4)Neuropsychiatric disease
- •5)Severe respiratory insufficiency
- •6)History of drug allergy
- •7)Sedative drug use within 24 hours before the surgery
研究者
相似试验
招募中
Unknown
A Prospective, Comparative Clinical Study of Two Sedatives for Patients Needing Invasive Breathing Support (Ventilator) in ICCTRI/2023/03/051210one
已完成
不适用
A Clinical Trial of Levocarnitine to Treat Autism Spectrum DisordersAutism Spectrum Disorder (ASD)Mental and Behavioural DisordersPervasive developmental disordersISRCTN54273114Autism Research Institute (USA)30
进行中（未招募）
不适用
A RANDOMIZED DOUBLE-BLIND PARALLELL GROUP CLINICAL STUDY OF XENETIX 300 VERSUS VISIPAQUE 270 IN MULTISLICE CT PEDIATRIC INDICATIONS - XENETIX 300 VS VISIPAQUE 270 IN MSCT IN CHILDREPatients requiring MSCT with contrast medium injection for diagnosisEUCTR2005-000664-51-GBGUERBET142
进行中（未招募）
不适用
A RANDOMIZED DOUBLE-BLIND PARALLELL GROUP CLINICAL STUDY OF XENETIX 300 VERSUS VISIPAQUE 270 IN MULTISLICE CT PEDIATRIC INDICATIONS - PEDIATRIC MSCTPatients requiring MSCT with contrast medium injection for diagnosisEUCTR2005-000664-51-ATGUERBET142
进行中（未招募）
1 期
A clinical trial for a guided early administration of antibiotics for presumed infection at the EREUCTR2018-001008-13-GRHELLENIC INSTITUTE FOR THE STUDY OF SEPSIS220